Expectations that a vaccine against COVID-19 will be available within a year’s time are mixed, based on recent surveys conducted by BioSpace, as well as the analytics company GlobalData.

Nearly three-quarters of U.S. physicians (73 percent) reported not being able to test patients quickly and easily for coronavirus, despite 50 percent reporting that they had treated at least one patient with possible COVID-19 symptoms, according to a nationwide survey of more than 2,600 physicians on the Doximity network.

According to a study released by Infogroup, a provider of data and data-driven intelligence solutions, four in five consumers say they are more concerned about privacy than they used to be – a tendency marketers ought to keep in mind.

A quarter of healthcare organizations’ revenue is tied to value-based payments, according to a survey by the healthcare data analytics and policy company DataGen. Those with 550 or more beds reported the largest portion of risk, with an average of 37.9 percent of revenue tied to VBP.

Physician-patient engagement has changed rapidly and significantly during the COVID-19 pandemic, with remote conferencing and digital communications becoming increasingly important, according to a new survey of 500 U.S physicians by health and wellness marketing agency AbelsonTaylor.

A new survey conducted by Fingerpaint – a full-service health and wellness marketing agency – about the use of telemedicine shows that a majority (76%) of healthcare practitioners (HCPs) agree it is convenient for their patient, but most (64%) think it is not as effective as engaging with their patient in an office.

Healthcare practitioners (HCPs) are not only worried about how they will get through COVID-19, but they are also concerned about the long-term well-being of their patients. A new survey published by Fingerpaint, a full-service health and wellness marketing agency, shows that the top concern regarding the pandemic for a majority of HCPs revolves around their patients having access to care – and those concerns are not expected to change for months.

In a competitive market, brands rely on their reputations to give them an edge. However, these reputations are built on perceptions — and because it’s up to consumers to develop their own perceptions, brands may feel as though they have less control in developing lasting loyalty. This is especially true in the pharmaceutical industry due to where pharmaceutical manufacturers reside within healthcare’s value chain. In the patient-doctor relationship, pharmaceutical companies are the left-out third wheel.

Join moderator Lynne Devlin, Registered Nurse and VP of Clinical Outreach Services, for a conversation with three people living with cancer about how the threat of COVID-19 is different for them.

A quantitative survey conducted by Continuum Clinical shows clinical research study sites are rapidly becoming more concerned about COVID-19-related interruptions to clinical trial recruitment and retention, with U.S. site concern jumping from 25 percent to 47 percent – an 88 percent increase over just 4 days.